Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson’s disease models in vitro and vivo

PURPOSE: Parkinson's disease (PD) is the second most common neurodegenerative disease without cure or effective treatment. This study explores whether the yeast internal NADH-quinone oxidoreductase (NDI1) can functionally replace the defective mammalian mitochondrial complex I, which may provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongzhi, Sun, Bohao, Huang, Yuting, Zhang, Jing, Xu, Xuejing, Shen, Yuqi, Chen, Zhuo, Yang, Jifeng, Shen, Luxi, Hu, Yongwu, Gu, Haihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900322/
https://www.ncbi.nlm.nih.gov/pubmed/35255803
http://dx.doi.org/10.1186/s10020-022-00456-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900322/
https://www.ncbi.nlm.nih.gov/pubmed/35255803
http://dx.doi.org/10.1186/s10020-022-00456-x

Ejemplares similares